Class information for:
Level 1: GLYCOGEN SYNTHASE KINASE 3//GSK 3//GLYCOGEN SYNTHASE KINASE 3 BETA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3883 1887 54.2 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
385 3       MICROGLIA//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM 31368
1808 2             LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 6256
3883 1                   GLYCOGEN SYNTHASE KINASE 3//GSK 3//GLYCOGEN SYNTHASE KINASE 3 BETA 1887

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GLYCOGEN SYNTHASE KINASE 3 authKW 1160075 10% 39% 183
2 GSK 3 authKW 804356 7% 36% 138
3 GLYCOGEN SYNTHASE KINASE 3 BETA authKW 643686 8% 27% 147
4 GSK 3 BETA authKW 437307 7% 21% 130
5 GSK 3 INHIBITORS authKW 317005 1% 85% 23
6 GLYCOGEN SYNTHASE KINASE 3 GSK 3 authKW 214116 2% 44% 30
7 LITHIUM authKW 205123 15% 4% 287
8 GSK3 BETA authKW 198161 4% 16% 75
9 TDZD 8 authKW 176178 1% 78% 14
10 GSK 3 BETA INHIBITOR authKW 158558 1% 70% 14

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 5488 32% 0% 612
2 Psychiatry 1696 12% 0% 221
3 Biochemistry & Molecular Biology 1576 27% 0% 509
4 Chemistry, Medicinal 1464 9% 0% 168
5 Cell Biology 1110 14% 0% 266
6 Pharmacology & Pharmacy 1002 16% 0% 295
7 Clinical Neurology 321 7% 0% 136
8 Oncology 262 8% 0% 155
9 Biophysics 83 4% 0% 67
10 Behavioral Sciences 42 2% 0% 29

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PSYCHIAT BEHAV NEUROBIOL 129199 3% 13% 62
2 MOL NEUROBIOL SECT 121859 2% 21% 36
3 EXPT MED NEPHROL CRIT CARE MED 80901 0% 100% 5
4 SPARKS 1057 72498 1% 41% 11
5 SPARKS 46629 0% 41% 7
6 NEUROSIGNALLING GRP 36404 0% 75% 3
7 MOL PATHOPHYSIOL 33866 1% 7% 28
8 MOL PATHOPHYSIOL MOOD ANXIETY DISORDERS PRO 32360 0% 100% 2
9 SPARKS 1001A 32360 0% 100% 2
10 MOL DESIGN NUTR ENGN NINGBO CITY 29354 0% 26% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FRONTIERS IN MOLECULAR NEUROSCIENCE 12220 1% 4% 21
2 BIPOLAR DISORDERS 4384 1% 1% 19
3 INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 2322 1% 1% 16
4 CURRENT ALZHEIMER RESEARCH 1692 1% 1% 10
5 MOLECULAR PSYCHIATRY 1573 1% 1% 15
6 JOURNAL OF NEUROCHEMISTRY 1434 2% 0% 44
7 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 1403 3% 0% 48
8 PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 1160 1% 0% 19
9 ACS CHEMICAL NEUROSCIENCE 857 0% 1% 7
10 JOURNAL OF ALZHEIMERS DISEASE 778 1% 0% 15

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GLYCOGEN SYNTHASE KINASE 3 1160075 10% 39% 183 Search GLYCOGEN+SYNTHASE+KINASE+3 Search GLYCOGEN+SYNTHASE+KINASE+3
2 GSK 3 804356 7% 36% 138 Search GSK+3 Search GSK+3
3 GLYCOGEN SYNTHASE KINASE 3 BETA 643686 8% 27% 147 Search GLYCOGEN+SYNTHASE+KINASE+3+BETA Search GLYCOGEN+SYNTHASE+KINASE+3+BETA
4 GSK 3 BETA 437307 7% 21% 130 Search GSK+3+BETA Search GSK+3+BETA
5 GSK 3 INHIBITORS 317005 1% 85% 23 Search GSK+3+INHIBITORS Search GSK+3+INHIBITORS
6 GLYCOGEN SYNTHASE KINASE 3 GSK 3 214116 2% 44% 30 Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3 Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3
7 LITHIUM 205123 15% 4% 287 Search LITHIUM Search LITHIUM
8 GSK3 BETA 198161 4% 16% 75 Search GSK3+BETA Search GSK3+BETA
9 TDZD 8 176178 1% 78% 14 Search TDZD+8 Search TDZD+8
10 GSK 3 BETA INHIBITOR 158558 1% 70% 14 Search GSK+3+BETA+INHIBITOR Search GSK+3+BETA+INHIBITOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 BEUREL, E , GRIECO, SF , JOPE, RS , (2015) GLYCOGEN SYNTHASE KINASE-3 (GSK3): REGULATION, ACTIONS, AND DISEASES.PHARMACOLOGY & THERAPEUTICS. VOL. 148. ISSUE . P. 114 -131 165 57% 61
2 ELDAR-FINKELMAN, H , MARTINEZ, A , (2011) GSK-3 INHIBITORS: PRECLINICAL AND CLINICAL FOCUS ON CNS.FRONTIERS IN MOLECULAR NEUROSCIENCE. VOL. 4. ISSUE . P. - 118 59% 71
3 O'LEARY, O , NOLAN, Y , (2015) GLYCOGEN SYNTHASE KINASE-3 AS A THERAPEUTIC TARGET FOR COGNITIVE DYSFUNCTION IN NEUROPSYCHIATRIC DISORDERS.CNS DRUGS. VOL. 29. ISSUE 1. P. 1 -15 110 61% 7
4 LI, XH , JOPE, RS , (2010) IS GLYCOGEN SYNTHASE KINASE-3 A CENTRAL MODULATOR IN MOOD REGULATION?.NEUROPSYCHOPHARMACOLOGY. VOL. 35. ISSUE 11. P. 2143-2154 105 59% 123
5 MAQBOOL, M , MOBASHIR, M , HODA, N , (2016) PIVOTAL ROLE OF GLYCOGEN SYNTHASE KINASE-3: A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 107. ISSUE . P. 63 -81 80 50% 11
6 RAYASAM, GV , TULASI, VK , SODHI, R , DAVIS, JA , RAY, A , (2009) GLYCOGEN SYNTHASE KINASE 3: MORE THAN A NAMESAKE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 156. ISSUE 6. P. 885 -898 83 62% 225
7 ARFEEN, M , BHARATAM, PV , (2013) DESIGN OF GLYCOGEN SYNTHASE KINASE-3 INHIBITORS: AN OVERVIEW ON RECENT ADVANCEMENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 26. P. 4755 -4775 104 63% 9
8 PANDEY, MK , DEGRADO, TR , (2016) GLYCOGEN SYNTHASE KINASE-3 (GSK-3)-TARGETED THERAPY AND IMAGING.THERANOSTICS. VOL. 6. ISSUE 4. P. 571 -593 81 63% 3
9 MARTINEZ, A , (2008) PRECLINICAL EFFICACY ON GSK-3 INHIBITORS: TOWARDS A FUTURE GENERATION OF POWERFUL DRUGS.MEDICINAL RESEARCH REVIEWS. VOL. 28. ISSUE 5. P. 773-796 86 67% 56
10 SANI, G , NAPOLETANO, F , FORTE, AM , KOTZALIDIS, GD , PANACCIONE, I , PORFIRI, GM , SIMONETTI, A , CALORO, M , GIRARDI, N , TELESFORO, CL , ET AL (2012) THE WNT PATHWAY IN MOOD DISORDERS.CURRENT NEUROPHARMACOLOGY. VOL. 10. ISSUE 3. P. 239-253 97 57% 11

Classes with closest relation at Level 1


Rank Class id link
1 23068 RYK//EXCELENCIA BIOMED MAGALLANES CEBIMA//DERAILED
2 20818 INOSITOL MONOPHOSPHATASE//MYO INOSITOL MONOPHOSPHATASE//INOSITOL
3 8695 LITHIUM//IST SCI HSR//MOL NEUROPSYCHOPHARMACOL PROGRAM
4 19697 4C4//BLOOD LITHIUM//REPROD ENDOCRINE PHYSIOL
5 981 BETA CATENIN//AXIN//WNT
6 30540 LITHIUM EXPOSURE//LITHIUM LOW PROTEIN DIET//MINING WASTE WATERS
7 361 TAU//TAUOPATHY//PAIRED HELICAL FILAMENTS
8 19622 DISC1//DISRUPTED IN SCHIZOPHRENIA 1//FEZ1
9 18233 INDIRUBIN//TRYPTANTHRIN//ISATIS TINCTORIA
10 25904 MOOD DISORDERS PROGRAMMED 1//PROGRAM HLTH SCIHLTH SCI UNIT//AGRN

Go to start page